Towards this direction, it was demonstrated that targeting SCD1 for inhibition increases apoptosis of renal carcinoma cells in vitro and in vivo [19] and lung cancer cells in vivo [27], while in ovarian cancer, FASN inhibitors induce cell cycle blockage and stimulate apoptosis. Here, FASN is linked to ovarian cancer.